Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn’s disease

Ruemmele, F.M., Veres, G., Kolho, K.L., Griffiths, A., Levine, A., Escher, J.C., Amil Dias, J., Barabino, A. +25 more·2014·Journal of Crohn s and Colitis
DOI 10.1016/j.crohns.2014.04.005

Cites (293)

Items 201–291 of 291

  1. Efficacy and Safety of Adalimumab in Canadian Patients with Moderate to Severe Crohn’s Disease: Results of the Adalimumab in Canadian SubjeCts with ModErate to Severe Crohn’s DiseaSe (ACCESS) Trial
    Remo Panaccione, Edward V. Loftus, David G. Binion, Kevin McHugh, Shamsul Alam, Naijun Chen, B. Guérette, Parvez M Mulani, Jingdong Chao · 2011 · Canadian Journal of Gastroenterology
  2. Risk of Infection and Prevention in Pediatric Patients With IBD
    Gigi Veereman‐Wauters, Lissy de Ridder, Gábor Veres, Sanja Kolaček, John M E Fell, Petter Malmborg, Sibylle Koletzko, Jorge Amil Dias, Zrinjka Mišak, Jean‐François Rahier et al. · 2012 · Journal of Pediatric Gastroenterology and Nutrition
  3. Efficacy and Tolerance of Infliximab in Children and Adolescents with Crohn’s Disease
    Thierry Lamireau, Jean‐Pierre Cézard, A. Dabadie, Olivier Goulet, Alain Lachaux, Dominique Turck, Chantal Maurage, Alain Morali, Etienne Marc Sokal, Dominique C. Belli et al. · 2004 · Inflammatory Bowel Diseases
  4. Methotrexate: New Uses for an Old Drug
    Philip J. Hashkes, Mara L. Becker, David A. Cabral, Ronald M. Laxer, Amy S. Paller, C. Egla Rabinovich, Dan Turner, Francesco Zulian · 2013 · The Journal of Pediatrics
  5. Inflammatory bowel disease and lymphoproliferative disorders: the dust is starting to settle
    Harry Sokol, Laurent Beaugerie · 2009 · Gut
  6. Infliximab Therapy in Children With Concurrent Perianal Crohn Disease: Observations From REACH
    Wallace Crandall, Jeffrey S. Hyams, Subra Kugathasan, Anne Marie Griffiths, Julie Zrubek, Allan David Olson, Grace Liu, Robert B. Heuschkel, James F. Markowitz, Stanley Allen Cohen et al. · 2009 · Journal of Pediatric Gastroenterology and Nutrition
  7. Safety of Infliximab Treatment in Pediatric Patients with Inflammatory Bowel Disease
    Craig A. Friesen, Cheryl Calabro, Kathy M. Christenson, Ellen Stahl Carpenter, Eleanor Welchert, James F. Daniel, Sara Haslag, Charles C. Roberts · 2004 · Journal of Pediatric Gastroenterology and Nutrition
  8. Infliximab dependency in pediatric Crohnʼs disease: Long-term follow-up of an unselected cohort
    Lissy de Ridder, Edmond H.H.M. Rings, Gerard M. Damen, C. M. F. Kneepkens, Joachim J. Schweizer, Freddy T. M. Kokke, Marc Alexander Benninga, Obbe F. Norbruis, Hans J. Hoekstra, Carolien F.M. Gijsbers et al. · 2007 · Inflammatory Bowel Diseases
  9. Anti-infliximab antibodies in inflammatory bowel disease
    Lennard Y. W. Lee, Jeremy David Sanderson, Peter Miles Irving · 2012 · European Journal of Gastroenterology & Hepatology
  10. Systematic Review of the Evidence Base for the Medical Treatment of Paediatric Inflammatory Bowel Disease
    DC Wilson, Adrian G. Thomas, Nicholas Michael Croft, Elizabeth A Newby, Anthony Kwaku Akobeng, Andrew Sawczenko, John M E Fell, MS Murphy, R Mark Beattie, BK Sandhu et al. · 2010 · Journal of Pediatric Gastroenterology and Nutrition
  11. Long-term Outcome of Patients With Crohn's Disease Who Respond to Azathioprine
    Marine Camus, Philippe Seksik, Anne Bourrier, Isabelle Nion–Larmurier, Harry Sokol, Philippe Baumer, Laurent Beaugerie, Jacques Cosnes · 2012 · Clinical Gastroenterology and Hepatology
  12. Long term outcome of patients with active Crohn's disease exhibiting extensive and deep ulcerations at colonoscopy
    Matthieu Allez · 2002 · The American Journal of Gastroenterology
  13. Efficacy of Different Therapeutic Options for Spontaneous Abdominal Abscesses in Crohnʼs Disease: Are Antibiotics Enough?
    Fernando Bermejo, Elena Garrido, María Chaparro, Jordi Gordillo, Míriam Mañosa, Alicia Algaba, Antonio López–Sanromán, Javier P. Gisbert, Esther García-Planella, Iván Guerra et al. · 2011 · Inflammatory Bowel Diseases
  14. Methotrexate for maintenance of remission in Crohn's disease
    Vishal H Patel, John K MacDonald, John WD McDonald, Nilesh Chande · 2009 · Cochrane Database of Systematic Reviews
  15. Tolerance and efficacy of azathioprine in pediatric Crohnʼs disease
    Laura Riello, Cécile Talbotec, Hélène Garnier‐Lengliné, Bénédicte Pigneur, Johan C. E. Svahn, Danielle Canioni, Olivier Goulet, J. Schmitz, Frank M. Ruemmele · 2011 · Inflammatory Bowel Diseases
  16. Slow-Release 5-Aminosalicylic Acid Therapy in Children with Small Intestinal Crohnʼs Disease
    Anne Marie Griffiths, Sibylle Koletzko, Francisco A. Sylvester, MARGARET A. MARCON, Philip M. Sherman · 1993 · Journal of Pediatric Gastroenterology and Nutrition
  17. Infliximab Dependency in a National Cohort of Children with Crohn's Disease
    Vibeke Wewer, Lene Buhl Riis, Ida Vind, Steffen Husby, Pia Munkholm, Anders Pærregaard · 2005 · Journal of Pediatric Gastroenterology and Nutrition
  18. Efficacy and safety of thalidomide in children and young adults with intractable inflammatory bowel disease: long‐term results
    Marzia Lazzerini, Stefano Martelossi, Federico Marchetti, Aldo Scabar, Fulvio Bradaschia, Luca Ronfani, Alessandro Ventura · 2007 · Alimentary Pharmacology & Therapeutics
  19. The effects of anti-TNF-α treatment with adalimumab on growth in children with Crohn's disease (CD)
    S. Malik, S. Faisal Ahmed, M.L. Wilson, Neil Shah, S Loganathan, S. Naik, Billy Bourke, Adrian G Thomas, Anthony Kwaku Akobeng, Andrew Adebayo Fagbemi et al. · 2011 · Journal of Crohn s and Colitis
  20. Lymphoma risk in children and young adults with inflammatory bowel disease: Analysis of a large single-center cohort
    Lori A. Ashworth, Amy Louise Billett, Paul D. Mitchell, Federica Nuti, Corey Allan Siegel, Athos Bousvaros · 2011 · Inflammatory Bowel Diseases
  21. Use of an Intravenous Steroid Regimen in the Treatment of Acute Crohn???s Disease
    Hugh A. Shepherd, G. D. Barr, D P Jewell · 1986 · Journal of Clinical Gastroenterology
  22. The impact of infliximab induction therapy on mucosal healing and clinical remission in Polish pediatric patients with moderate-to-severe Crohn’s disease
    Jarosław Kierkuś, Maciej Dądalski, Edyta Szymańska, Grzegorz Oracz, Agnieszka Wegner, Monika Górczewska, Sylwia Szymańska, Marek Woynarowski, Józef Ryżko · 2012 · European Journal of Gastroenterology & Hepatology
  23. Methotrexate in the treatment of inflammatory bowel disease: An 8-year retrospective study in a Canadian pediatric IBD center
    Stephanie Willot, Angela J. Noble, Colette Deslandres · 2011 · Inflammatory Bowel Diseases
  24. Effect of Different Corticosteroid Regimens on Hypothalamic-pituitary-adrenal Axis and Growth in Juvenile Chronic Arthritis
    Margie Byron, J Jackson, Barbara M. Ansell · 1983 · Journal of the Royal Society of Medicine
  25. Stopping immunomodulators and biologics in inflammatory bowel disease patients in remission
    Kofi Clarke, Miguel D. Regueiro · 2011 · Inflammatory Bowel Diseases
  26. Methotrexate in patients with Crohn's diease after 6-mercaptopurine
    Mack · 1998 · Jornal de Pediatria
  27. Hepatotoxicity Caused by Methotrexate Therapy in Children with Inflammatory Bowel Disease
    Pamela L. Valentino, Peter C. Church, Prakesh S. Shah, Joseph Beyene, Anne Marie Griffiths, Brian Michael Feldman, Binita Maya Kamath · 2013 · Inflammatory Bowel Diseases
  28. 12‐Month Follow‐up After Successful Infliximab Therapy in Pediatric Crohn Disease
    Jan Wynands, Reda Belbouab, Sophie Candon, Cécile Talbotec, Jean‐François Mougenot, Lucienne Chatenoud, J. Schmitz, Jean‐Pierre Cézard, Olivier Goulet, Jean‐Pierre Hugot et al. · 2008 · Journal of Pediatric Gastroenterology and Nutrition
  29. Pediatric Inflammatory Bowel Diseases and the Risk of Lymphoma: Should We Revise Our Treatment Strategies?
    Salvatore Cucchiara, Johanna Caroline Escher, Hans Hildebrand, Jorge Amil Dias, Laura Stronati, Frank M. Ruemmele · 2009 · Journal of Pediatric Gastroenterology and Nutrition
  30. Antitumor necrosis factor treatment for pediatric inflammatory bowel disease
    Charlotte I. de Bie, Johanna Caroline Escher, Lissy de Ridder · 2011 · Inflammatory Bowel Diseases
  31. High‐dose azathioprine in children with inflammatory bowel disease
    D. Fuentes, Franco Torrente, Simon Keady, Kumran Thirrupathy, Mike A. Thomson, John A. Walker-Smith, SIMON H MURCH, Robert B. Heuschkel · 2003 · Alimentary Pharmacology & Therapeutics
  32. Postoperative Infliximab Is Not Associated with An Increase in Adverse Events in Crohn’s Disease
    Miguel D. Regueiro, Sandra El‐Hachem, Kevin E. Kip, Wolfgang H. Schraut, Leonard Baidoo, Andrew Watson, Jason M. Swoger, Marc B. Schwartz, Arthur M. Barrie, Marilyn Pesci et al. · 2011 · Digestive Diseases and Sciences
  33. A single center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: A case for subcutaneous administration
    Debbie M. Nathan, John H. Iser, Peter R. Gibson · 2007 · Journal of Gastroenterology and Hepatology
  34. Does polymeric formula improve adherence to liquid diet therapy in children with active Crohn's disease?
    Astor Rodrigues, T Johnson, P. S. W. Davies, Michael S. Murphy · 2007 · Archives of Disease in Childhood
  35. Lung Lesions in Children With Crohn's Disease Presenting as Nonresolving Pneumonias and Response to Infliximab Therapy
    Sankaran Krishnan, Agnes Banquet, Leonard Newman, Umadevi S. Katta, Asawari Patil, Allen J. Dozor · 2006 · PEDIATRICS
  36. Methotrexate Treatment in Pediatric Crohn Disease Patients Intolerant or Resistant to Purine Analogues
    B. Weiß, Aaron Lerner, Rivka Shapiro, Efrat Broide, A Levine, Akiva Fradkin, Yoram Bujanover · 2009 · Journal of Pediatric Gastroenterology and Nutrition
  37. Azathioprine in paediatric inflammatory bowel disease: an Italian multicentre survey
    Arrigo Vittorio Barabino, Franco Torrente, Alessandro Ventura, Salvatore Cucchiara, M. Castro, C. Barbera · 2002 · Alimentary Pharmacology & Therapeutics
  38. Role of Thiopurine Metabolite Testing and Thiopurine Methyltransferase Determination in Pediatric IBD
    Keith J. Benkov, Ying Lu, Ashish Patel, Riad M. Rahhal, Gary Russell, Jonathan E. Teitelbaum · 2013 · Journal of Pediatric Gastroenterology and Nutrition
  39. Initial clinical experience with allopurinol-thiopurine combination therapy in pediatric inflammatory bowel disease
    Riad M. Rahhal, Warren P. Bishop · 2008 · Inflammatory Bowel Diseases
  40. Successful Treatment of Metastatic Crohn Disease With Infliximab
    Johanna Caroline Escher, Tom J. Stoof, Sander J. H. van Deventer, A. Marceline van Furth · 2002 · Journal of Pediatric Gastroenterology and Nutrition
  41. Combined azithromycin and metronidazole therapy is effective in inducing remission in pediatric Crohn's disease
    Arie Levine, Dan Turner · 2011 · Journal of Crohn s and Colitis
  42. Oral locally active steroids in inflammatory bowel disease
    Tiago Nunes, Manuel Barreiro‐de Acosta, Ignacio Marín‐Jiménez, Pilar Nos, Miquel Sans · 2012 · Journal of Crohn s and Colitis
  43. Azathioprine Maintains first remission in newly diagnosed pediatric Crohnʼs disease
    Gerald J. Jaspers, Henkjan J. Verkade, Johanna Caroline Escher, Lissy de Ridder, Jan A. J. M. Taminiau, Edmond H.H.M. Rings · 2006 · Inflammatory Bowel Diseases
  44. Severe adverse reactions to Infliximab therapy are common in young children with inflammatory bowel disease
    K‐L Kolho, Tarja Ruuska, Emma Merike Savilahti · 2006 · Acta Paediatrica
  45. 1159 Results on the Optimisation Phase of the Prospective Controlled Trough Level Adapted Infliximab Treatment (TAXIT) Trial
    Niels Vande Casteele, Griet Compernolle, Vera Ballet, Gert Van Assche, Ann Gils, Séverine Vermeire, Paul J. Rutgeerts · 2012 · Gastroenterology
  46. Postoperative Therapy for Crohnʼs Disease
    Eric B. Blum, Jeffry Katz · 2008 · Inflammatory Bowel Diseases
  47. Evaluation of oral budesonide for treatment of mild and moderate exacerbations of Crohn's disease in children
    Arie Levine, Efrat Broide, Michal Stein, Yoram Bujanover, Zvi Weizman, Gabriel Dinari, Avi Pacht, David Branski, Ilan Zahavi · 2002 · The Journal of Pediatrics
  48. Role of Methotrexate in the Management of Crohn Disease
    Madhur Ravikumara, Ann Hinsberger, Christine Helen Spray · 2007 · Journal of Pediatric Gastroenterology and Nutrition
  49. Thalidomide Use and Outcomes in Pediatric Patients With Crohn Disease Refractory to Infliximab and Adalimumab
    Lina Maria Felipez, Ranjana R. Gokhale, Matthew Tierney, Barbara S. Kirschner · 2011 · Journal of Pediatric Gastroenterology and Nutrition
  50. Infliximab‐induced Psoriasis in Children With Inflammatory Bowel Disease
    Girish S Hiremath, Lynn F. Duffy, Ian Leibowitz · 2011 · Journal of Pediatric Gastroenterology and Nutrition
  51. Alterations in Nutritional Status and Disease Activity during Treatment of Crohn's Disease with Elemental Diet
    K Teahon, Morag Pearson, T Smith, Ingvar Bjarnason · 1995 · Scandinavian Journal of Gastroenterology
  52. Use and Safety of Rifaximin in Children With Inflammatory Bowel Disease
    Pramodha Muniyappa, Reema Gulati, Franziska Mohr, Vera F. Hupertz · 2009 · Journal of Pediatric Gastroenterology and Nutrition
  53. Steroid dependency and pediatric inflammatory bowel disease in the era of immunomodulators—A population-based study
    Christian Jakobsen, Pia S. Munkholm, Anders Pærregaard, Vibeke Wewer · 2010 · Inflammatory Bowel Diseases
  54. Short‐course Ondansetron for the Prevention of Methotrexate‐induced Nausea in Children With Crohn Disease
    Anna Kempinska, Eric Ian Benchimol, Amanda Mack, Janice L. Barkey, Margaret Boland, David R. Mack · 2011 · Journal of Pediatric Gastroenterology and Nutrition
  55. Étude des répercussions psychologiques de deux modalités de traitement chez des adolescents atteints de maladie de Crohn
    Lise Gailhoustet, Olivier Goulet, N. Cachin, J. Schmitz · 2002 · Archives de Pédiatrie
  56. Comparison of two dosing methods for induction of response and remission with oral budesonide in active pediatric Crohnʼs disease: A randomized placebo-controlled trial
    Arie Levine, Michal Kori, Gabriel Dinari, Efrat Broide, Ron R. Shaoul, Baruch Yerushalmi, Avi On, Yoram Bujanover, Markus Proels, Roland Greinwald · 2009 · Inflammatory Bowel Diseases
  57. Are Thiopurines Always Contraindicated After Thiopurine‐Induced Pancreatitis in Inflammatory Bowel Disease?
    Oren Ledder, Daniel A. Lemberg, Chee Yee Ooi, Andrew Stewart Day · 2013 · Journal of Pediatric Gastroenterology and Nutrition
  58. A Single‐center Experience With Methotrexate After Thiopurine Therapy in Pediatric Crohn Disease
    Brendan Boyle, Laura M. Mackner, Christina S. Ross, Jonathan Moses, Soma Kumar, Wallace Crandall · 2010 · Journal of Pediatric Gastroenterology and Nutrition
  59. Prevention of relapse by mesalazine (Pentasa®) in pediatric Crohn's disease: A multicenter, double-blind, randomized, placebo-controlled trial
    Jean‐Pierre Cézard, À. Munck, O. Mouterde, Alain Morali, Catherine Lenaerts, Alain Lachaux, Dominique Turck, J. Schmitz, Chantal Maurage, J.-P. Girardet et al. · 2009 · Gastroentérologie Clinique et Biologique
  60. Infliximab Delays but Does Not Avoid the Need for Surgery in Treatment-Resistant Pediatric Crohn’ Disease
    Nadeem Ahmad Afzal, Andrew Ozzard, Simon Keady, Mike A. Thomson, SIMON H MURCH, Robert B. Heuschkel · 2007 · Digestive Diseases and Sciences
  61. Infliximab in Pediatric Crohn Disease Patients With Enterovesicular Fistulas
    Jonathan E. Teitelbaum, Shehzad Ahmed Saeed, Maria Triantafyllopoulou, Frederic Daum · 2007 · Journal of Pediatric Gastroenterology and Nutrition
  62. Anti-TNF trough levels and detection of antibodies to anti-TNF in inflammatory bowel disease: are they ready for everyday clinical use?
    Pál Miheller, Lajos Sandor Kiss, Katalin Lőrinczy, Peter Laszlo Lakatos · 2011 · Expert Opinion on Biological Therapy
  63. Glucocorticoids in pediatric inflammatory bowel disease
    Marianne Sidoroff, Kaija‐Leena Kolho · 2012 · Scandinavian Journal of Gastroenterology
  64. A case of posterior reversible encephalopathy syndrome in a child with Crohn's disease treated with Infliximab
    Rosemary Haddock, Vikki Garrick, Iain A. Horrocks, Richard Kay Russell · 2011 · Journal of Crohn s and Colitis
  65. The effect of adalimumab for induction of endoscopic healing and normalization of mucosal cytokine gene expression in Crohn's disease
    Renathe Rismo, Trine Olsen, Guanglin Ciu, Eyvind J. Paulssen, Ingrid Christiansen, Jon Florholmen, Rasmus Goll · 2012 · Scandinavian Journal of Gastroenterology
  66. A semielemental diet (Pregomin) as primary therapy for inducing remission in children with active Crohn’s disease.
    Gianluca Terrin, Roberto Berni Canani, Anna Ambrosini, Franca Viola, Mirjam Bueno de Mesquita, Giovanni Di Nardo, Lucia Dito, Salvatore Cucchiara · 2002 · IRIS Research product catalog (Sapienza University of Rome)
  67. Can we reduce the dosage of biologics in spondyloarthritis?
    Ignazio Olivieri, Salvatore D’Angelo, Angela Anna Padula, Pietro Leccese, Angelo Nigro, Carlo Palazzi · 2012 · Autoimmunity Reviews
  68. Pharmacokinetics and pharmacodynamic action of budesonide in children with Crohn's disease
    K. Dilger, Martin Alberer, A. BUSCH, Axel Enninger, Rolf Behrens, Sibylle Koletzko, Martin Stern, C. BECKMANN, Christoph H. Gleiter · 2006 · Alimentary Pharmacology & Therapeutics
  69. Prevention of acute adverse events related to infliximab infusions in pediatric patients
    Pekka Lahdenne, Anne M. Wikström, Kristiina T Aalto, Kaija‐Leena Kolho · 2010 · Arthritis Care & Research
  70. Bioavailability of 5-aminosalicylic acid from slow release 5-aminosalicylic acid drug and sulfasalazine in normal children
    Lisbet Ambrosius Christensen, Jan Fallingborg, Bent Ascanius Jacobsen, Kirsten Abildgaard, H.H. Rasmussen, Sten Nørby Rasmussen, Steen Honoré Hansen · 1993 · Digestive Diseases and Sciences
  71. Management of Fulminating Ulcerative Colitis in Childhood with Chimeric Anti‐CD25 Antibody
    A. Schwarzer, Ida Ricciardelli, Sian Kirkham, K Binnie, Neil Shah, Mamoun Elawad, Susan M. Hill, Mark A. Furman, V. V. Smith, Neil James Sebire et al. · 2006 · Journal of Pediatric Gastroenterology and Nutrition
  72. Prevention of recurrence after surgery for Crohn’s disease: Efficacy of infliximab
    Takayuki Yamamoto · 2010 · World Journal of Gastroenterology
  73. A prospective evaluation of the impact of allopurinol in pediatric and adult IBD patients with preferential metabolism of 6-mercaptopurine to 6-methylmercaptopurine
    Mark E. Gerich, Jose Antonio Quiros, James P. Marcin, Linda Tennyson, Maria Henthorn, Thomas P. Prindiville · 2010 · Journal of Crohn s and Colitis
  74. Glucocorticoid sensitivity in inflammatory bowel disease
    Marianne Sidoroff, Kaija‐Leena Kolho · 2011 · Annals of Medicine
  75. Pharmacokinetics of Mesalazine Pellets in Children With Inflammatory Bowel Disease
    H.E. Wiersma, Johanna Caroline Escher, Karin Dilger, Dietmar Trenk, Marc Alexander Benninga, Chris J. van Boxtel, Jan A. J. M. Taminiau · 2004 · Inflammatory Bowel Diseases
  76. 925j Optimising post-operative Crohn's disease management: best drug therapy alone versus colonoscopic monitoring with treatment step-up. The POCER study.
    Peter P. De Cruz, Michael A. Kamm, Amy L. Hamilton, Kathryn J. Ritchie, Soula Krejany, Alexandra Gorelik, Danny Liew, Lani Prideaux, Ian Craig Lawrance, Jane Mary Andrews et al. · 2013 · Gastroenterology
  77. 979 Impact of Concomitant Immunomodulator Treatment on Efficacy and Safety of Anti-TNF Therapy in Crohn's Disease: A Meta-Analysis of Placebo Controlled Trials With Individual Patient-Level Data
    Jennifer Jones, Gilaad G. Kaplan, Laurent Peyrin‐Biroulet, Leonard Baidoo, Shane M. Devlin, GIL Y. MELMED, Divine Tanyingoh, Laura H. Raffals, Peter Miles Irving, Patricia L. Kozuch et al. · 2013 · Gastroenterology
  78. Oral 5-Aminosalicylic Acid in Children with Colonic Chronic Inflammatory Bowel Disease
    Vasundhara K. Tolia, Neil Massoud, Ulrich E. Klotz · 1989 · Journal of Pediatric Gastroenterology and Nutrition
  79. Circulating Adiponectin as a Marker for Glucocorticoid‐related Side Effects in Children and Adolescents With Inflammatory Bowel Disease
    Marianne K Vihinen, Kaija‐Leena Kolho, Olli A. Jänne, Sture Andersson, Taneli Raivio · 2009 · Journal of Pediatric Gastroenterology and Nutrition
  80. Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn's disease
    Morris A. Gordon, Khimara Naidoo, Adrian G. Thomas, Anthony Kwaku Akobeng · 2010 · Cochrane Database of Systematic Reviews
  81. Mucosal Healing in Children with Crohnʼs Disease
    Athos Bousvaros · 2004 · Inflammatory Bowel Diseases
  82. The long-term efficacy of azathioprine does not wane after four years of continuous treatment in patients with steroid-dependent luminal Crohn’s disease
    Gerassimos J. Mantzaris, Anastasios Roussos, Angeliki Christidou, Stavroula Koilakou, Chryssostomos Kalantzis, Kalliopi Petraki, Michael E. Sfakianakis, Alexander Karagiannidis, Paraskevi Polyzou · 2007 · Journal of Crohn s and Colitis
  83. Recognition and treatment of genitourinary complications in paediatric Crohn’s disease using Infliximab
    Nadeem Ahmad Afzal, MU Shenoy, Sarah Haque, Duncan T. Wilcox, Neil Shah · 2010 · Acta Paediatrica
  84. Changes in Inflammation and QoL After a Single Dose of Infliximab During Ongoing IBD Treatment
    Mark Daniel DeBoer, Barrett H. Barnes, Nicholas Stygles, James L. Sutphen, Stephen Mark Borowitz · 2011 · Journal of Pediatric Gastroenterology and Nutrition
  85. 41 Serious Infections and Associated Risk Factors in Patients Receiving Infliximab and Immunotherapies for Children With Inflammatory Bowel Disease: Develop Registry Data
    Robert N. Baldassano, Richard B. Colletti, Salvatore Cucchiara, Marla Cindy Dubinsky, Johanna Caroline Escher, William A. Faubion, John M E Fell, Benjamin D. Gold, Anne Marie Griffiths, Jeffrey S. Hyams et al. · 2013 · Gastroenterology
  86. 833 Malignancies in Children Receiving Infliximab and Other Inflammatory Bowel Disease Therapies: An Inflammatory Bowel Disease Multicenter, Prospective, Long-Term Registry of Pediatric Patients (Develop) Registry Data
    Richard B. Colletti, Salvatore Cucchiara, Marla Cindy Dubinsky, Johanna Caroline Escher, William A. Faubion, John M E Fell, Benjamin D. Gold, Anne Marie Griffiths, Jeffrey S. Hyams, Sibylle Koletzko et al. · 2013 · Gastroenterology
  87. Prevention of infusion reactions to infliximab in paediatric patients with oral acetylsalicylic acid.
    Anssi Hämäläinen, Pekka Lahdenne, Anne M. Wikström, Kristiina T Aalto, Kaija‐Leena Kolho · 2012 · PubMed
  88. Recurrent Mucinous Carcinoma Masquerading as an Abscess
    James M. Williamson, Eleanore J. D. Massey, Nathan J. Coombs · 2010 · Clinical Gastroenterology and Hepatology
  89. A Ghost Pancreas
    Arnaud Galbois, Fabien Stenard, Dimitri Margetis · 2011 · Gastroenterology
  90. Mucosal Healing in Pediatric Crohnʼs Disease
    Johanna Caroline Escher · 2004 · Inflammatory Bowel Diseases
  91. P525 Efficacy infliximab with immunomodulator and infliximab alone of maintenance therapy in children with Crohn's disease – multicenter randomized study
    Jarosław Kierkuś, B. Iwanczyk, Agnieszka Wegner, Maciej Dądalski, Urszula Grzybowska‐Chlebowczyk, I. Lazowska, Jolanta Maślana, Ewa Toporowska‐Kowalska, Grażyna Czaja‐Bulsa, Grażyna Mierzwa et al. · 2013 · Journal of Crohn s and Colitis